178 related articles for article (PubMed ID: 52967)
1. Urinary excretion of 5-S-cysteinyldopa in patients with primary melanoma or melanoma metastasis.
Agrup G; Agrup P; Andersson T; Falck B; Hansson J-A ; Jacobsson S; Rorsman H; Rosengrem A-M ; Rosengren E
Acta Derm Venereol; 1975; 55(5):337-41. PubMed ID: 52967
[TBL] [Abstract][Full Text] [Related]
2. 5-S-cysteinyldopa in the urine of melanoma patients.
Agrup G; Agrup P; Andersson T; Falck B; Hansson JA; Jacobsson S; Rorsman H; Rosengren E; Rosengren AM
Acta Derm Venereol; 1977; 57(2):113-6. PubMed ID: 71802
[TBL] [Abstract][Full Text] [Related]
3. 5 years' experience of 5-S-cysteinyldopa in melanoma diagnosis.
Agrup G; Agrup P; Andersson T; Hafström L; Hansson C; Jacobsson S; Jönsson PE; Rorsman H; Rosengren AM; Rosengren E
Acta Derm Venereol; 1979; 59(5):381-8. PubMed ID: 93360
[TBL] [Abstract][Full Text] [Related]
4. [5-S-cysteinyldopa in the urine - a "tumor test" for malignant melanoma? Comparison with the usual laboratory examinations].
Paul E; Graef V; Ruppel R
Z Hautkr; 1980 Dec; 55(23):1543-60. PubMed ID: 6782780
[TBL] [Abstract][Full Text] [Related]
5. [5-S-cysteinyldopa determination in the urine. Its value for monitoring in melanoma patients].
Paul E; Graef V; Ruppel R; Hellwich M
Z Hautkr; 1983 Feb; 58(4):262-5. PubMed ID: 6405551
[TBL] [Abstract][Full Text] [Related]
6. Urinary 5-S-cysteinyldopa in Parkinsonism after DOPA and carbidopa.
Stewart RM; Miller S; Gunder M
Acta Derm Venereol; 1983; 63(2):97-101. PubMed ID: 6189350
[TBL] [Abstract][Full Text] [Related]
7. 5-S-cysteinyldopa in the plasma of melanoma patients and the renal clearance of this amino acid.
Agrup G; Andersson T; Falck B; Persson K; Rorsman H; Rosengren AM; Rosengren E
Acta Derm Venereol; 1975; 55(1):5-6. PubMed ID: 46673
[TBL] [Abstract][Full Text] [Related]
8. Cysteinyldopa isomers and dopa in lesions and urine of Japanese patients with malignant melanoma.
Morishima T; Tatsumi F; Fukada E; Saito M; Fujita M; Nagashima N; Hanawa S
Arch Dermatol Res; 1983; 275(2):76-9. PubMed ID: 6409012
[TBL] [Abstract][Full Text] [Related]
9. [Urinary 5-S-cysteinyldopa levels in patients with malignant melanoma. Preliminary results].
Césarini JP; Meunier M
Rev Prat; 1975 Nov; 25(51):4037-9. PubMed ID: 1209143
[No Abstract] [Full Text] [Related]
10. [Urinary 5-S-cysteinyldopa in malignant melanoma subjects-with special reference to melanoma stages and dopa loading test (author's transl)].
Ichihasi M; Mojamdar M; Mishima Y
Nihon Hifuka Gakkai Zasshi; 1981 Sep; 91(10):1045-9. PubMed ID: 6798247
[No Abstract] [Full Text] [Related]
11. Demonstration of 3-methoxytyrosine in the urine of melanoma patients.
Agrup G; Bengtsson M; Falck B; Persson K; Rorsman H; Rosengren AM; Rosengren E
Acta Derm Venereol; 1976; 56(1):27-31. PubMed ID: 56853
[TBL] [Abstract][Full Text] [Related]
12. Urine excretion of 5-S-cysteinyldopa and serum sialic acid as tumor markers in human melanomas.
Marnot D; Decaux F; Berthelot P; Kalis B; Jardillier JC; Warren L
Cancer Detect Prev; 1983; 6(1-2):303-10. PubMed ID: 6411338
[TBL] [Abstract][Full Text] [Related]
13. Measurement of eumelanin precursor metabolites in the urine as a new marker for melanoma metastases.
Yamada K; Walsh N; Hara H; Jimbow K; Chen H; Ito S
Arch Dermatol; 1992 Apr; 128(4):491-4. PubMed ID: 1580656
[TBL] [Abstract][Full Text] [Related]
14. [Comparative studies between excretion of 5-S-cysteinyldopa and indole melanogens in urine].
Beyer C; Fiedler H; Wohlrab W; Wozniak KD
Dermatol Monatsschr; 1986; 172(9):541-4. PubMed ID: 3098590
[No Abstract] [Full Text] [Related]
15. Melanin-related metabolites in urine of B16 melanoma-bearing mice.
Wakamatsu K; Ito S; Fujita K
Acta Derm Venereol; 1988; 68(5):385-9. PubMed ID: 2461020
[TBL] [Abstract][Full Text] [Related]
16. The urinary melanogen cysteinyldopa in melanoma and in suntanning: Australian experience.
Nixon PF
Aust N Z J Surg; 1978 Feb; 48(1):17-21. PubMed ID: 276342
[TBL] [Abstract][Full Text] [Related]
17. Seasonal variation in urinary excretion of 5-S-cysteinyldopa in healthy Japanese.
Ito S; Kato T; Fujita K
Acta Derm Venereol; 1987; 67(2):163-5. PubMed ID: 2438883
[TBL] [Abstract][Full Text] [Related]
18. [Melanoma metabolites (proceedings)].
Rorsman H
Lakartidningen; 1978 Dec; 75(49):4596-7. PubMed ID: 723347
[No Abstract] [Full Text] [Related]
19. [Correlation of urinary 5-S-cysteinyldopa with repeated remission of melanoma induced by DTIC combination chemotherapy].
Inoi T; Mojamdar M; Ichihashi M; Mishima Y
Nihon Hifuka Gakkai Zasshi; 1982 Sep; 92(10):1065-9. PubMed ID: 6821170
[No Abstract] [Full Text] [Related]
20. Trichochromuria in melanosis of melanoma.
Rorsman H; Agrup P; Carlén B; Hansson C; Jonsson N; Rosengren E; Tegner E
Acta Derm Venereol; 1986; 66(6):468-73. PubMed ID: 2433864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
